iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Get Free Report) shares saw strong trading volume on Thursday . 289,496 shares changed hands during trading, an increase of 189% from the previous session’s volume of 100,329 shares.The stock last traded at $95.85 and had previously closed at $95.08.
iShares U.S. Pharmaceuticals ETF Stock Up 1.0%
The business’s 50 day moving average is $90.05 and its two-hundred day moving average is $88.02. The firm has a market capitalization of $1.04 billion, a P/E ratio of 17.75 and a beta of 0.50.
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in the stock. Stratos Wealth Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at $555,000. D.A. Davidson & CO. acquired a new position in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter worth $1,709,000. Prevail Innovative Wealth Advisors LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter worth $4,529,000. Accurate Wealth Management LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter worth $6,372,000. Finally, Lee Johnson Capital Management LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the first quarter worth $1,603,000.
About iShares U.S. Pharmaceuticals ETF
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.
Further Reading
- Five stocks we like better than iShares U.S. Pharmaceuticals ETF
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for iShares U.S. Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
